Jetty A Overbeek
Overview
Explore the profile of Jetty A Overbeek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johannes C, Ziemiecki R, Pladevall-Vila M, Ebert N, Kovesdy C, Thomsen R, et al.
Diabetes Ther
. 2024 Dec;
16(2):205-226.
PMID: 39688776
Introduction: The clinical landscape for the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is rapidly evolving. As part of the FOUNTAIN platform (NCT05526157; EUPAS48148),...
2.
Faessen J, Oerlemans D, de Jong M, Overbeek J, Vissers P, Aben K, et al.
Bladder Cancer
. 2024 Jul;
9(1):73-82.
PMID: 38994479
Background: Observational studies indicate a potential association between diabetes medication use and aggressiveness of bladder cancer. Objective: The objective is to exploratively study the association between diabetes medication use, as...
3.
Holthuis E, Heins M, van Houdt W, Haas R, Overbeek J, Olde Hartman T, et al.
JCO Clin Cancer Inform
. 2024 Jul;
8:e2400054.
PMID: 38950319
There has been growing interest in the use of real-world data (RWD) to address clinically and policy-relevant (research) questions that cannot be answered with data from randomized controlled trials (RCTs)...
4.
Overbeek J, Nijpels G, Swart K, Blom M, Elders P, Herings R
Diabetes Metab Syndr Obes
. 2024 Apr;
17:1503-1509.
PMID: 38562280
Aims/hypothesis: Only a few studies reported the incidence of type 2 diabetes (T2D). Understanding recent trends in diabetes is vital for planning future diabetes care. This study updated national trends...
5.
Vervloet M, de Jong H, Pander J, Overbeek J
BMC Nephrol
. 2023 Nov;
24(1):337.
PMID: 37957561
Background: Knowledge on prevalence, comorbidities and consequences of chronic kidney disease (CKD) is mandatory to estimate the potential of cardiovascular risk management on a population level. We studied the prevalence...
6.
van Trier T, Snaterse M, Herings R, Overbeek J, Peters R, Jorstad H
Neth Heart J
. 2023 Oct;
32(1):45-54.
PMID: 37870710
Background: In patients with ischaemic heart disease (IHD) aged > 70 years, Dutch and European guidelines recommend different treatment targets: low-density lipoprotein cholesterol (LDL-c) < 2.6 versus < 1.4 mmol/l...
7.
Serne E, Overbeek J, Palmen J, de Jong H, Stehouwer C
Ned Tijdschr Geneeskd
. 2023 Sep;
167.
PMID: 37742128
Objective: Dutch diabetes guidelines have been updated to incorporate specific therapies with cardiovascular and kidney outcomes benefit in type 2 diabetes patients (T2D) at very high risk for cardiorenal complications....
8.
Swart K, van der Heijden A, Blom M, Overbeek J, Nijpels G, van Hout H, et al.
Br J Gen Pract
. 2023 Jul;
73(735):e752-e759.
PMID: 37487641
Background: Routinely collected clinical data based on electronic medical records could be used to define frailty. Aim: To estimate the ability of four potential frailty measures that use electronic medical...
9.
van den Berg J, Remmelzwaal S, Blom M, van Hoek B, Swart K, Overbeek J, et al.
Vaccines (Basel)
. 2023 Jan;
11(1).
PMID: 36679869
Persons with diabetes mellitus may have an increased risk of severe illness or death from COVID-19 compared to persons without diabetes. Prior studies indicate that immune response and thus vaccine...
10.
Overbeek J, Swart K, Houben E, Penning-van Beest F, Herings R
Clin Epidemiol
. 2023 Jan;
15:1-11.
PMID: 36636730
Purpose: When using incomplete or non-representative real-world data (RWD), bias is more likely to occur. The aim of the current study was to assess the completeness and representativeness of the...